Related Experiment Video
Updated: Apr 28, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
CD4-induced activation in a soluble HIV-1 Env trimer
Miklos Guttman1, Natalie K Garcia1, Albert Cupo2
1Department of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA.
Understanding HIV envelope glycoprotein (Env) conformational changes is key to fusion inhibition. This study reveals how CD4 binding and inhibitors alter Env structure, offering new insights for drug development.
Area of Science:
- Structural Biology
- Virology
- Biochemistry
Background:
- The HIV envelope glycoprotein (Env) trimer mediates viral entry by undergoing conformational changes upon receptor binding.
- Previous studies using low-resolution electron microscopy revealed large-scale Env rearrangements, but detailed structural dynamics remained unclear.
Purpose of the Study:
- To precisely understand the conformational changes in unliganded and CD4-bound soluble HIV Env trimers (SOSIP.664) using advanced biophysical techniques.
- To investigate the distinct effects of CD4 binding site-targeted inhibitors on Env structure and allosteric pathways.
Main Methods:
- Utilized hydrogen-deuterium exchange mass spectrometry (HDX-MS) and oxidative labeling.
- Analyzed the structural dynamics of soluble Env trimers (SOSIP.664) in unliganded and CD4-bound states.
- Assessed the impact of inhibitors NBD-556 and BMS-806 on Env conformation.
Main Results:
- CD4 binding triggers significant reorganization of Env, including bridging sheet elements, V1/V2 and V3 loops, gp120 inner domain, and the gp41 fusion subunit.
- The inhibitor NBD-556 partially mimics CD4-induced destabilization of the V1/V2 and V3 regions.
- BMS-806 exhibits a more localized effect, primarily impacting the gp120/gp41 interface.
Conclusions:
- Provides high-resolution structural insights into CD4-mediated allosteric changes in the HIV Env trimer.
- Demonstrates differential mechanisms of action for CD4 binding site inhibitors, informing future drug design.
- Enhances understanding of the structural pathways leading to HIV membrane fusion.
More Related Videos
11:45Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
Published on: March 8, 2012
10:50Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
Published on: September 15, 2010